ECC5004 is in a Phase 1 clinical trial in the U.S
Yes, semaglutide (the active ingredient in Ozempic, Wegovy, Rybelsus, and other GLP-1 drugs) is well-known for causing GI side effects
The approval was based on data from two randomized, double-blind, placebo-controlled studies involving more than 3,000 overweight or obese adults
Brando C et al describieron un caso de hematoma abdominal en una mujer de 51 aos, que manifiesta un cuadro de dolor epigstrico, nuseas, vmitos y tumefaccin abdominal, que se agrava en el tiempo, de siete meses de duracin
Data on File Beiersdorf Study Report STDR-071541C
It is commonly used to support recovery from muscle, tendon, and joint injuries, reduce inflammation, and support gut and digestive health